NF1

17 clinical trials · Condition

Record	Firm	Date
Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1 (NCT05238909)	Ann & Robert H Lurie Children's Hospital of Chicago	2022-03-04
A Phase II Trial of Poly-ICLC for Low-Grade Gliomas (NCT04544007)	University of Alabama at Birmingham	2022-02-08
Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1 (NCT04954001)	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	2021-03-26
Interventions for Reading Disabilities in NF1 (NCT02964884)	Vanderbilt University	2016-11-01
Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas (NCT01402817)	Indiana University	2012-03-01
AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors (NCT01362803)	National Cancer Institute (NCI)	2011-09-21
Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas (NCT01275586)	Indiana University	2011-01-01
Adaptation and Quality of Life Among Adults With Neurofibromatosis Type I (NCT00684398)	National Human Genome Research Institute (NHGRI)	2008-05-15
Study of Plexiform Neurofibromas in Neurofibromatosis Type 1 (NCT00006435)	National Cancer Institute (NCI)	2001-05-18

Every clearance here is in the API, with alerts when new ones post.